New Studies Reinforce Important Role Real-World Patient Data Can Play in Developing Value-based Reimbursement Strategies

News provided by

May 27, 2015, 08:30 ET

DUBLIN, Ohio, May 27, 2015 /PRNewswire/ -- Later this week, Cardinal Health Specialty Solutions will present a new series of health economic outcomes research (HEOR) studies that reinforce the importance of evaluating real-world treatment patterns when developing value-based reimbursement strategies.

Dr. Bruce Feinberg, vice president and chief medical officer of Cardinal Health Specialty Solutions, says that physicians, payers and pharmaceutical companies alike have known for more than a decade that clinical trials alone do not accurately reflect how cancer treatment happens in the real world. Feinberg maintains that payers are seeing this disparity, and are adjusting reimbursement strategies as a result.

"With an increased focus on value-based care, which relies on real-world clinical evidence, clinical trial data no longer provides enough information to develop appropriate reimbursement models," said Feinberg. "This new research reinforces that HEOR data can help payers better understand the effectiveness of treatments in real-world settings; and that it can be used to better determine value-based reimbursement strategies."

Over the past year, Cardinal Health Specialty Solutions has published numerous studies on real-world treatment patterns in leukemia and lymphoma care; and the economic impact of that care on patients. Building upon this body of work, Cardinal Health Specialty Solutions will publish a new set of clinical studies focused on renal cell carcinoma at the American Society of Clinical Oncology (ASCO) meeting May 29- June 2, 2015 in Chicago.

To view full abstracts of the company's research being featured at the 2015 ASCO Annual Meeting, click here. Attendees of the ASCO Annual Meeting can also learn more by visiting Cardinal Health Specialty Solutions' booth #4041 at the 2015 ASCO Annual Meeting.

About Cardinal Health Specialty Solutions

Cardinal Health Specialty Solutions provides clinical, reimbursement, technology and distribution services that help health care professionals, payers and pharmaceutical and biotech companies improve the quality and cost-effectiveness of caring for patients who are managing complex diseases. Cardinal Health Specialty Solutions helps customers alleviate day-to-day administrative burdens, optimize business functions and partner to implement new innovations that move their businesses forward. To learn more, visit www.cardinalhealth.com/specialtysolutions.

About Cardinal Health
Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is a $91 billion health care services company that improves the cost-effectiveness of health care. As the business behind health care, Cardinal Health helps pharmacies, hospitals, ambulatory surgery centers, clinical laboratories and physician offices focus on patient care while reducing costs, enhancing efficiency and improving quality. Cardinal Health is an essential link in the health care supply chain, providing pharmaceuticals and medical products and services to more than 100,000 locations each day and is also the industry-leading direct-to-home medical supplies distributor. The company is a leading manufacturer of medical and surgical products, including gloves, surgical apparel and fluid management products. In addition, the company operates the nation's largest network of radiopharmacies that dispense products to aid in the early diagnosis and treatment of disease. Ranked #22 on the Fortune 500, Cardinal Health employs 34,000 people worldwide. More information about the company may be found at www.cardinalhealth.com and @CardinalHealth on Twitter.